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Abstract
Background: Babies born at lower gestational ages or smaller birthweights have a greater risk of poorer health in later life.
Both the causes of these sub-optimal birth outcomes and the mechanism by which the effects are transmitted over decades
are the subject of extensive study. We investigated whether a transcriptomic signature of either birthweight or gestational
age could be detected in umbilical cord RNA.
Methods: The gene expression patterns of 32 umbilical cords from Singaporean babies of Chinese ethnicity across a range
of birthweights (1698–4151 g) and gestational ages (35–41 weeks) were determined. We confirmed the differential
expression pattern by gestational age for 12 genes in a series of 127 umbilical cords of Chinese, Malay and Indian ethnicity.
Results:We found that the transcriptome is substantially influenced by gestational age; but less so by birthweight. We show
that some of the expression changes dependent on gestational age are enriched in signal transduction pathways, such as
Hedgehog and in genes with roles in cytokine signalling and angiogenesis. We show that some of the gene expression
changes we report are reflected in the epigenome.
Conclusions: We studied the umbilical cord which is peripheral to disease susceptible tissues. The results suggest that
soma-wide transcriptome changes, preserved at the epigenetic level, may be a mechanism whereby birth outcomes are
linked to the risk of adult metabolic and arthritic disease and suggest that greater attention be given to the association
between premature birth and later disease risk.
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Introduction
Birth outcomes defined by gestational age and birth weight have
far reaching consequences across the life-course. For instance
young adults born prematurely or at very low birthweights have
significantly lower bone density than do their larger and term-born
peers [1]. The prenatal environment has been linked to the risk of
disease in later life [2,3,4,5,6,7,8]. Children born either prema-
turely or small for gestational age have reduced insulin sensitivity
and are at higher risk for type 2 diabetes mellitus [7,8]. Little is
known of the molecular mechanisms by which these longer-term
consequences for the offspring are transmitted, although epige-
netic mechanisms appear to be implicated [9]. Umbilical cord
tissue is a readily available tissue and offers a source of RNA and
DNA for an assessment of the genomic and epigenomic state of the
neonate. Molecular biomarkers that reveal early life experience
and predict later disease risk would be valuable as a means to
identify high-risk patients, and could be a starting point to
designing therapeutic interventions [9,10,11]. While several
groups have found transcriptomic [12,13] and epigenetic marks
[14,15,16,17,18,19,20,21] in the umbilical cord associated with
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extreme intrauterine experience or birth outcomes, of particular
interest to us and relevant to global health concerns are the
molecular mechanisms of inter-individual variability operating
within the normal range [22], as long-term effects of the prenatal
state can be readily demonstrated within children of normal
birthweight and gestation [9,23,24].
GUSTO (Growing Up in Singapore Towards healthy Out-
comes) is a Singapore-based birth cohort study [25]. From this
deeply phenotyped cohort we profiled the transcriptome of 32
umbilical cords collected at birth from ethnic Chinese babies in
Singapore hospitals. Transcriptomic change significantly related to
gestational age were discovered and then validated by q-PCR
analysis across an expanded set of 127 multiethnic samples.
Pathway analysis revealed enrichment of differential transcription
by gestational age in hedgehog signalling genes: GLI2, GLI3, and
SMO, and others downstream of the pathway with a role in
skeletal development, defects of which are associated with early-
onset osteoarthritis. In addition, inflammatory mediators such as
CXCL14 and Il1RL1 were differentially expressed, as well as
HSD11B1, a gene with known implications in development [26].
Furthermore, a subset of the differentially expressed genes was
found to also differ in DNA methylation levels in a manner
associated with gestational age. We suggest that lower birth weight
and particularly earlier (within the near term range) gestational
ages, leaves an epigenetic echo that affects the risk for diseases such
as type 2 diabetes mellitus and osteoarthritis in later life.
Results
To ascertain the independent roles of both gestational age and
birth weight, which are positively correlated, we selected normal
birth weight samples to match the gestational ages of the extreme
birth weight samples [Figure 1 and Table 1], and subjected them
to expression microarray analysis. After probe quality control and
inter-sample quantile normalisation of the 32 RNA samples
interrogated on the array, the data for two samples failed quality
control (MAD scores ,25) and were removed from subsequent
analyses. The removed samples were from the #37 week_NBW
and from the.37 w_NBW groups and are highlighted in Figure 1.
Three series of technical replicates were included in the
experiment, they clustered together in 10 cases out of 12; when
the full dataset was subjected to unsupervised hierarchical
clustering demonstrating that the intra-sample variation is lower
than the inter-sample variation [Figure S1]. Therefore the data
were declared of acceptable quality and the replicates were
combined.
To examine the pattern of relatedness between individual
transcriptomes and to identify potential underlying associations
with birth outcomes, principal component analysis was performed
on the dataset. We found that within the normal birth weight
samples, PC1 separated the samples by gestational age (p,0.05,
R= 0.76) [Figure 2A]. When extreme birth weight samples were
included in the analysis, there was still a separation by gestational
age, but the correlation was not as strong (p,0.05, R = 0.55)
[Figure 2B]. However there was no significant relationship
(p,0.05) with birth weight, gender or maternal age for any of
the first five components returned from the principal component
analysis. Therefore we concluded that the majority of the signal in
the dataset is driven by gestational age and not by birth weight,
suggesting that for infants born within the normal range of birth
weights and gestational ages, gestational age is a stronger driver of
umbilical cord transcriptomes than is birth weight.
Next, we utilized linear regression to identify which probe
expression levels were most highly correlated with gestational age,
and then determine if any associated with birth weight. As
predicted from the above, we found more probes for which
expression correlated with gestational age, (530 had a p-value
,0.001) [Table S1] than with birthweight (8 had a p-value
,0.001) [Table S2]. Some of the probes most strongly correlated
with gestational age mapped to hedgehog ligand GLI2 [Figure
S2A] and hedgehog receptor smoothened, SMO [Figure S2B].
Figure S3 shows the correlation of expression of a probe mapping
to transforming growth factor receptor beta 1 (TGFBR1) with
birthweight.
ANOVA tests were performed to identify gene expression
associated with gestational age, by comparing the normal birth
weight samples from the two different gestational age groups
delimited by 37 weeks (i.e. #37 w_NBW vs. .37 w_NBW), 64
probes passed an FDR correction for multiplicity of q,0.05
[Table S3]. Other probes with nominally significant p-values
(,0.05) (not passing FDR) and outlier fold changes included those
mapping to desmocollin 1 (DSC1), a cadherin protein involved in
epithelial cell adhesion in desmosomes [27], which had the highest
fold change [Figure S2C]. We also performed an ANOVA on all
samples grouped by gestational age regardless of birthweight, and
DSC1 still had the one of the highest fold changes [Figure S2D].
The 64 probes which passed FDR in the gestational age
comparison were capable of organising the samples by gestational
age when used in hierarchical clustering. Clustering on just the
normal birth weight samples gave the cleanest result [Figure 3A].
However, when the extreme birth weight samples were included,
the bifurcating pattern still significantly separated the samples in
respect to their gestational age (average gestational age of left
branch = 36.96 weeks, average gestational age of right branch
= 39.12 t-test p-value = 0.0003) [Figure 3B].
We also performed ANOVAs to identify genes for which
transcript levels were differential for birth weight, by comparing
the low birth weight (LBW) group with the #37 w_NBW group;
and the high birth weight (HBW) group with the .37 w_NBW
group. No probes passed an FDR correction for multiplicity
(adjusted p,0.05), in either comparison. Eight probes correspond-
ing to five known genes co-varied with BW (p,0.05) and had
p,0.05, fc.1.5 in both ANOVA tests [Table S4 and Figure S3].
We selected some of the strongest expression changes along with
some of the more interesting genes from a disease-related
perspective and assayed their expression levels in 127 additional
samples. Twenty-two genes in all were tested with a range of
significance in the array data (Table S5). Generally there was a
concordance between the magnitude of the fold change in the
ANOVA and repetition in the expansion set (average absolute fold
change replicating group (shown in figure 4 and table S5) = 2.52,
average absolute fold change non-replicating group (shown in
table S5) = 1.47, t-test p= 0.026). The replicating group comprises
genes whose mRNA levels had a significant relationship with
gestational age in the qPCR expanded study. The non-replicating
group are those genes whose mRNA levels did not achieve
significance against gestational age in the expanded qPCR study.
Of this set, 12 genes showed p,0.1 in a t-test between the less than
37 weeks gestational age (,37 w) and more than 37 weeks
gestational age (.37 w) groups, they are illustrated in Figure 4.
Pathway enrichment analysis was performed on the 45 genes
mapping to the 64 probes which had FDR ,0.05 for gestational
age. The most enriched gene ontology (GO) process was skeletal
system development (Fisher’s exact test p-value = 8.4e25), with 4/
129 genes related to this processes showing significant changes:
MATN3, MSX1, PITX1 and BMP8B.
Pathway enrichment analysis was also performed on 445 genes
mapping to the 530 probes co-varying with gestational age
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(p,0.001, by univariate regression). The most enriched GeneGO
map was ‘‘Hedgehog and PTH signalling pathways in bone and
cartilage development’’ (Fisher’s exact test p-value = 3.3e24) with
5/24 genes for the pathway showing significant changes: SMO,
GNAS, GLI2, COL1A1 and COL1A2. We also noted that the
expression of GLI3, another central component of the hedgehog
pathway, was correlated with gestational age. Components of
hedgehog signalling and bone development pathways have been
shown to interact with each other, and we were able to generate a
subnetwork of genes enriched for differential expression for
gestational age [Figure 5]. For most of the genes in figure 5,
transcript levels were higher in the #37 week gestation group.
Schroeder et al (2011) [28] showed that the DNA methylation
profile of umbilical cords reflects gestational age. Therefore, we
surveyed the DNA methylome of a representative subset of twenty,
of the samples originally examined by gene expression micro-
arrays. Of the twelve genes with validated differential expression
by gestational age (Figure 4), eight genes (67%) had concordant
differential CpG methylation levels by gestational age (Pearson
covariate ,0.05) [Table 2]. Of note were the three canonical
members of the Hedgehog signalling pathway GLI2, GLI3 and
SMO, which showed methylation at multiple CpGs varying with
gestational age. A specific CpG dinucleotide in the 59UTR of GLI3
(cg17530977) was one of the 41 CpGs whose methylation levels
reached experiment-wide significance for gestational age in
Schroeder et al (2011) [28]. While this CpG was not significant
in our study, other similarly located CpGs close to the 59UTR,
transcription start site and within the gene body suggest coherent
results with Schroeder et al’s findings. Intriguingly we found a
significant correlation across samples for a subset of CpGs in
table 2, both by comparing the values within each sample with no
regard to phenotype and by comparing the ratios between
Figure 1. RNA Expression Microarray Study Design. Gestational age in weeks (y-axis) and birth-weight in grams (x-axis) of the samples
analysed by expression microarrays are symmetrical to allow somewhat independent comparisons for birth-weight and gestational age. Samples are
classified into high birth weight group (.3700 g) in orange; low birthweight group (,2500 g) in green; normal birthweight and gestational age less
than or equal to 37 weeks in blue; or normal birthweight and gestational age more than 37 weeks in red. Two samples that failed QC are shown as
non-filled circles.
doi:10.1371/journal.pone.0039744.g001
Table 1. Demographic and Characteristics of the Participants.
RNA expression array (n=32) PCR (n =120) DNA methylation array (n =20)
N (%) Mean (SD) N (%) Mean (SD) N (%) Mean (SD)
Gender Female 16 (50%) 51 (43%) 11 (55%)
Male 16 (50%) 69 (58%) 9 (45%)
GA (weeks) #37 weeks 14 (44%) 36 (1) 9 (8%) 36 (1) 10 (50%) 36 (1)
.37 weeks 18 (56%) 39 (1) 111 (93%) 39 (1) 10 (50%) 40 (1)
BW (g) LBW (,2500) 8 (25%) 2056 (1799) 24 (20%) 2280 (125) 5 (25%) 2069 (202)
NBW (2500–3700) 16 (50%) 3099 (191) 67 (56%) 3141 (320) 10 (50%) 3046 (153)
HBW (.3700) 8 (25%) 4076 (62) 29 (24%) 4073 (319) 5 (25%) 4086 (51)
Ethnic Group Chinese 32 (100%) 58 (48%) 20 (100%)
Malay 37 (31%)
Indian 25 (21%)
Parity 0.6 (1) 0.9 (1) 0.6 (1)
Maternal age 34 (4) 34 (4) 31 (5) 35 (3)
doi:10.1371/journal.pone.0039744.t001
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differential gestational age pairs (Text S1). Similarly, we also
considered DNA methylation changes in the eight genes showing
the most significant differential expression for birthweight, and
found 4 (33%) with significant methylation differences by
birthweight [table S6].
Discussion
Babies born at lower gestational ages and birth weights carry an
increased susceptibility for a range of diseases [29,30,31,32,33,34],
although there is considerable variation in outcome at the level of
the individual. Prognostic markers, such as expression levels of
candidate genes, might predict which individuals are on a
developmental path towards a higher risk of disease, particularly
as these trajectories need not involve children of abnormal
gestational age or birthweight. We were able to study gene
expression pattern in umbilical cords over a broad birthweight
range and explored the spectrum of near-term and term
gestational ages, i.e. from 35 to 41 weeks by leveraging the
availability of birth tissue specimens collected within the Singapore
GUSTO cohort study.
Our study was designed to investigate the molecular correlates
of both birthweight and gestational age. Perhaps surprisingly,
considering the dominant focus on birth weight, we found that
gestational age (even when excluding prematurity), is a very
important factor driving the transcriptome. Birthweight, even at
extremes, is not. This finding is supported by two recent papers
sampling umbilical cord blood from Caucasian and African-
American mothers in the Conditions affecting Neurocognitive
Development and Learning in Early Childhood (CANDLE)
cohort. Adkins et al (2012) [35] failed to find significant
associations with birth weight at either the transcript or CpG
methylation level. However, Schroeder et al (2011) [28] found
significant associations of CpG methylation with gestational ages,
within the normal range. Our conclusion also is supported by the
work of Cohen et al (2007) [36] who also found transcriptome-
wide statistical associations with gestational age. Finally, at the
functional level, morphology in specific brain regions at 6-years of
age is better predicted by gestational age than by birth weight [37].
Our findings are in contrast to those of Mason et al (2010) [38]
who found the largest component of variation in the umbilical
Figure 2. The largest source of variation in the transcriptomics data is associated with gestational age across samples. Prinicipal
component analysis using the RNA expression microarray data across just the normal birthweight samples (A) or across all samples (B), returned
principal component 1 (x-axis) which has a significant correlation with gestational age of the samples. Samples are classified into high birth weight
group (.3700 g) in orange; low birthweight group (,2500 g) in green; normal birthweight and gestational age less than or equal to 37 weeks in
blue; or normal birthweight and gestational age more than 37 weeks in red.
doi:10.1371/journal.pone.0039744.g002
Figure 3. Expression signature for gestational age organises
samples into gestational age groups. Hierarchical clustering of
samples (columns) by the expression levels of the 64 probes (rows)
significantly associated with gestational age (adjusted p-value,0.05),
organises normal birth weight samples perfectly by gestational age
group (A) and organises all samples into two clusters with significantly
different gestational ages (B). Z-score normalised logged expression
levels are denoted in the heat map (green for low, red for high, white
for intermediate). X-axis colour bars denote sample classification: high
birth weight group (.3700 g) in orange; low birthweight group
(,2500 g) in green; normal birthweight and gestational age less than
or equal to 37 weeks in blue; or normal birthweight and gestational age
more than 37 weeks in red. Gestational age is also represented as a
continuous variable in the x-axis colour bar in (B) green for low, red for
high, white for intermediate.
doi:10.1371/journal.pone.0039744.g003
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cord blood transcriptome of neonates was not related to
gestational age. Differences in tissues and sample sets may explain
this inconsistency.
Our study suggested differential expression of the Hedgehog
pathway by gestational age. This conclusion is the result of
statistical analysis of the microarray data and only genes GLI2,
GLI3, SMO, COL1A1 and MATN3 have been independently
validated in the expanded qPCR sample set. The Hedgehog
pathway has been shown to affect chondrocyte and osteoblast
differentiation [39,40]. Fetal bone development accelerates in late
pregnancy and has a complex relationship with birthweight and
gestational age [41,42]. Lower gestational age and lower birth
weights are associated with lower bone mass in infancy and
adulthood [1,43] and possibly with later development of osteopo-
rosis [44,45]. Lewis et al (2012) [46] reported that a higher
placental PHLDA2 expression was associated with a lower fetal
femur growth velocity. Dennison et al (2001) [47], found that the
relationship between lumbar spine bone mineral density and
birthweight varied according to vitamin D receptor genotype.
In addition, we saw the differential expression in the microarray
data only, of the hedgehog target genes PITX1, MATN3, and
RUNX2. Expression of transcription factor PITX1 has been shown
during hind limb development in regions giving rise to cartilage
joints, long bones and skeletal muscles, while its partial inactiva-
tion led to a progressive formation of osteoarthritis-like phenotype
in aging Pitx1+/2 mice [48]. Polymorphisms in PITX1 have also
been recently associated with osteoarthritis in a Chinese popula-
tion [49]. MATN3 is a cartilage-specific matrix protein, mutations
in which result in early-onset osteoarthritis [50]. The RUNX2
transcription factor is also downstream of the hedgehog pathway
and necessary for chrondrocyte and osteoblast differentiation and
bone formation [51]. During osteoblast differentiation, RUNX2
upregulates the expression of bone matrix protein genes including
COL1A1, COl1A2 [52] and the BMP family [52], which were also
differentially expressed for gestational age in our study. Mutations
in COL1A1 and COL1A2 have implicated in the inheritance of
osteogenesis imperfecta and have a relationship with bone mineral
density in Chinese populations [53].
Other genes differentially expressed in umbilical cords in
relationship to gestational age and replicated in our qPCR study
fall into the cytokine and angiogenesis pathways. CXCL14 belongs
to the family of CXC cytokines with a function in monocyte
activation [54]. It has recently been associated with regulating
metabolism, as it was shown that overexpression enhances obesity
induced insulin resistance [55,56]. In contrast, CXCL142/2
knockout mice are leaner and have a lower body weight [57].
Increased expression levels of CXCL14 in #37 week gestation
babies may thus trigger a trajectory towards insulin resistance later
in life [7,58]. Interestingly, CXCL14 expression has been associated
with reactive oxygen species, whereby downregulation of CXCL14
leads to a stimulation of angiogenesis in head and neck cancer
[59]. The relatively high levels of CXCL14 in umbilical cord from
Figure 4. Twelve transcripts have differential expression levels in gestational age groups across the 120 sample replication set. Fold
change with regard to the median sample of the more than 37 weeks gestation group, is shown on the y-axis. Gene names are shown above each
panel. P-values from the 2 group tests are shown within each panel. Data is represented as a box plot where the 2–3 quartile range is within the box,
the median is denoted by a horizontal line within the box, the min and max are denoted by horizontal lines outside of the box and single outliers are
represented by crosses.
doi:10.1371/journal.pone.0039744.g004
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#37 week gestation babies may reflect a restrictive intrauterine
environment such as a dysfunctioning placenta [60]. The protein
IL1RL1 belongs to the interleukin 1 receptor family [61]. It is
involved in eosinophilic inflammation which is linked to the
allergic phenotype [62]. Moreover, polymorphisms in the IL1RL1
gene are associated with the onset of asthma in Caucasian
populations [63]. In our studies, we found a decreased mRNA
expression of IL1RL1 in cord tissue derived from Asian babies
born at lower gestational age. We do not know the functional
impact of this down-regulation of mRNA expression of IL1RL1
and whether there is an overshooting compensatory expression
later in development. IL-33 is the natural ligand for IL1RL1 and
promotes angiogenesis by stimulating endothelial NO synthase
[64]. Therefore, a decrease in NO production is directly linked to
lowered expression of the receptor for IL-33 (IL1RL1) and could
reflect a supporting causative factor in the etiology of fetal growth
restriction. Endothelial NO synthase (eNOS) is the primary
isoenzyme expressed in human placenta but was found to be
expressed in umbilical cord as well [65]. Insufficient nitric oxide
production may associate with the pathogenesis of preeclampsia, a
condition often leading to preterm birth. The activity of NO
synthase in women with placental insufficiency was reported to be
below normal levels [66].
Fetal development requires efficient umbilical blood flow, which
in turn depends on the fetal vascular tree within the placenta.
Enhanced angiogenesis influences neonatal birth weights and
pregnancy outcomes (reviewed in [67]). We saw decreased
expression of ANTXR2 in umbilical cords of less than 37 weeks
gestation babies, ANTXR2 was recently reported to promote
endothelial proliferation and morphogenesis during sprouting
angiogenesis [68].
The Hedgehog signalling pathway has many functions, but
separate from its function in bone formation (see above), the
Hedgehog signalling pathway also plays a role in angiogenesis
[69]. Using a model of mouse hind limb ischemia, Benameur et al.
have shown that the hedgehog pathway promotes neovascularisa-
tion via the activation of eNOS and therefore increased nitric oxide
production [70]. It is tempting to speculate about the nature of
hedgehog pathway activation at lower gestational ages and
whether activation of this pathway can be seen as a compensatory
mechanism to counteract the generally anti-angiogenic gene-
expression footprint observed in the #37 weeks gestation
neonates.
Another gene of interest expressed at decreased levels in the
#37 weeks gestation group was HSD11B1. HSD11B1 is a
bidirectional enzyme most associated with converting the inactive
metabolite cortisone to the cortisol, which promotes insulin
resistance and obesity [71]. Moreover, polymorphisms in
HSD11B1 have been linked to insulin resistance and metabolic
syndrome in multiple populations [72,73]. Transcript levels have
been shown to be elevated in fetal membranes at late gestation
[26] and to increase in mouse liver in response to high fat diets,
leading to greater levels of insulin and hepatic lipid accumulation
[74]. Both known hydroxysteroid-dehydrogenase isoforms
HSD11B1 and HSD11B2 play a crucial role in maintaining
physiological levels of maternal stress-induced glucocorticoids, and
dysregulation of enzyme activity can lead to IUGR in rodent
models [75] as well as human pregnancies [76]. The overexpres-
sion of isoform HSD11B1 in .37 weeks gestation neonates is in
line with published observations [26]. It is tempting to speculate
whether enzymatic activities of the HSD11 isoforms are changed
in a gestational age dependent manner, as this has been
demonstrated in children born small for gestational age with lack
of catch-up growth who were found to have lower activity of
HSD11B1 [77].
Figure 5. Subnetwork enriched for differential expression by gestational age. Nodes represent genes and are coloured by the fold change
of their transcripts by gestational age (blue for positive association with gestational age, pink for negative association). No probe for PTHR1 was
included on the array. Arrows represent literature-verified interactions and the colours denote the type of interaction (green for activation, red for
inhibition and blue for co-expression).
doi:10.1371/journal.pone.0039744.g005
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We suggest that differential expression observed in the umbilical
cord transcriptome corresponding to gestational age is partly
driven by specific DNA methylation changes. Schroeder et al
(2011) [28] found that gestational age within the normal range
significantly drives DNA methylation. Interestingly one of the
CpGs which reached experiment-wide significance in their study
was located in GLI3, a gene with transcript levels significantly
varying with gestational age in our study. We have also measured
the methylation state of the umbilical cords in our study and report
concordant relationships with DNA methylation for 8 of the 16
genes replicated in our qPCR study as having significant
concordance with gestational age at the expression level, including
hedgehog transcription factor GLI3.
DNA methylation is an epigenetic mechanism that could
explain the persistence of birth outcomes on disease susceptibility
in later life [78]. Relton et al (2012) [79] recently reported DNA
methylation variance in nine genes at birth, persisting to gene
expression differences at 11–13 years of age and associating with
body composition at nine years of age. Specific methylation
differences correlating to gestational age could drive both the
transcriptome of the umbilical cord at birth and have conse-
quences in specific tissues at later ages. We chose here to assay the
genomics of umbilical cord tissue as the only available somatic
tissue. It is unknown if the genomic state of the umbilical cord
correlates with that of the other tissues of the fetus, especially in
those that give rise to diseases that have developmental origins.
However, the available data suggests that DNA methylation
patterns are generally conserved across tissues and there are
examples of individually-variable epigenetic marks being soma-
wide [80]. Godfrey et al (2011) [9] have shown that methylation of
a site in the RXRa gene promoter in the umbilical cord correlates
with body composition in later life, suggesting widespread
influences across multiple tissues. It is a limitation of our study
that results on whole umbilical cord tissue cannot be attributed to
specific cell lineages. However, by using this heterogeneous tissue
we anticipate that we have enriched for soma-wide changes.
In this study, we have made use of frozen umbilical cord tissue
derived from an Asian population. By designing the study to
independently examine both birth weight and gestational age, we
were able to find expression changes significant for gestational age.
Furthermore, by combining gene expression microarray data with
corresponding data from the latest Infinium 450 K human
methylation bead array chip (Illumina), our results provide insights
into the epigenetic profile of babies with differing birth outcomes.
This may allow the development of novel predictive epigenetic
markers for non-communicable diseases prevalent in Asia.
Materials and Methods
Clinical Populations and Sample Collection
All specimens were from babies born at the KK Women’s and
Children’s Hospital (KKH) and the National University Hospital
(NUH), in Singapore. These hospitals are part of the GUSTO
birth cohort study [25]. Written parental consent to participate in
the study was given and hard copies are stored by the GUSTO
data team. Ethical approval for the study and the consent forms
and contents was granted, by the ethics boards of both KKH and
NUH, which are centralised Institute Review Board (CIRB) and
Domain Specific Review Board (DSRB), respectively. Gestational
age was defined from a dating ultrasound (10–12 weeks) followed
by an additional scan at 18–22 weeks.
The discovery microarray analysis sample set consisted of a total
of 32 umbilical cords from babies of Chinese ethnicity. Maternal
ages were restricted to between 20–40 years. It was designed to
include eight low birth weight samples (defined as ,2500 g), eight
high birth weight (.3700 g) samples and sixteen normal birth
weight babies with gestational ages matching the extreme
birthweight samples. The average birth weight in the GUSTO
cohort was 3081 g, which is comparable to the average across a
larger Singaporean sample of 3183 g. for a term infant (unpub-
lished data). All children had a gestational age in the range of 35–
37 (shorter gestational age) or 38–41 weeks (longer gestational
age), to allow comparison across the range of normal gestational
age. This resulted in four groups, each comparable for birthweight
and/or gestational age and matched for gender and maternal age.
The expanded replication sample set of 127 umbilical cords for
qPCR analysis did not include any of those from the discovery set,
and were from babies of Chinese, Indian and Malay ethnicities.
The 20 samples analysed for DNA methylation were a subset of
the discovery microarray analysis set of 32. [See Table 1 for
sample characteristics]. Umbilical cord tissue samples were
collected at the time of delivery, flushed with saline to remove
fetal blood and flash-frozen in liquid nitrogen within 30 min of
collection.
RNA Extraction
Umbilical cord tissue (300 mg) was first placed in a sterile
Dispomix tube and homogenized for 55 s for 3 cycles in 3 ml of
Trizol using the Dispomix (Medic Tools, AG, Zug, Switzerland).
After spinning down the debris, the supernatants were divided
equally into three 2 ml tubes. 200 ul of chloroform were added to
each tube, vortexed vigorously and centrifuged for 15 min at 4uC.
The aqueous phase was carefully transferred to a new tube
containing 1 ul of linear acrylamide. An equal amount of
isopropanol was added and mixed by inversion. After incubating
at 220uC overnight to precipitate the RNA, the pellet was
obtained by centrifuging at 13,200 rpm for 10 min at 4uC. The
RNA pellet was washed twice in 70% (v/v) ethanol, air-dried and
resuspended in RNase-free water. The isolated RNA was then
purified using the RNeasy Mini Kit (Qiagen, Hilden, Germany).
On-column DNase digestion was carried out before the first wash
step according to the manufacturer’s instructions. The purified
RNA was then eluted in 30 ml of RNase-free water and stored at
280uC. RNA concentration and purity were measured using a
nanodrop ND-8000 spectrophotometer (Nanodrop Technologies,
Wilmington, DE, USA), and RNA integrity was determined using
the Agilent 2100 Bioanalyzer and RNA 6000 Nano Labchips
(Agilent Technologies, Santa Clara, CA, USA).
Expression Microarray
Gene expression analysis was carried out with 3 sets of duplicate
technical replicates from the 32 study subjects. All subsequent
experimental steps followed the manufactures instructions. Briefly,
Cy3-labelled cRNA was generated from 100 ng of total RNA
using the Quick Amp Labelling Kit (One-Color) (Agilent
Technologies, Santa Clara, CA, USA). Hybridization perfor-
mance was assessed by means of 10 proprietary spike-in controls
incorporated into the cRNA synthesis procedure. The labelled
cRNA was then purified and hybridized onto Agilent SurePrint
G3 Human Gene Expression (8660 K) microarrays in a rotating
(10 rpm) hybridization oven for 17 h at 65uC, after which they
were washed and processed with proprietary buffers and solutions.
The microarrays were then scanned at a resolution of 3 mm on an
Agilent scanner using an extended dynamic range (PMT 10/100).
The image data were processed using default values in feature
extraction version 10.7.1.1 (Agilent Technologies, Santa Clara,
CA, USA).
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Agilent ‘‘.txt’’ files were outputted from the scanner and loaded
into Arraystudio (Omicsoft). Signal extraction was performed from
the gProcessedSignal value incorporating background subtraction.
All expression values were log transformed. All probes with
expression levels less than two standard deviations above
background were removed. Values across replicate probes were
averaged. Data were normalised amongst samples using quantile
normalisation. Two samples with MAD scores ,25 were
removed from the analysis. Duplicate data for the same sample
were averaged. Data were subjected to principal component
analysis and unsupervised hierarchical clustering (correlation
distance, complete link). To identify probes significantly correlated
with gestational age, both univariate regression and one-way
ANOVAs (multiple testing correction: Benjamimi Hochberg) were
performed.
Processed and raw data is deposited in GEO, series accession=
GSE37100.
Quantitative Real Time-PCR
erse transcribed using a High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems Inc, ABI, CA, USA).
PCR reactions were prepared using 10 ul of Power SyBr Green
PCR 26Master mix (Applied Biosystems Inc, ABI, Foster City,
CA, USA), 1 ul of each primer (2 uM), and 20 ng of cDNA in a
total reaction volume of 20 ul. One hundered and twenty seven
new samples were selected and PCR for each sample was done in
triplicates in 384-well plates using the ABI 7900 HT Sequence
Detection System. Cycle parameters used were 10 min at 95uC (1
cycle), then 15 s at 95uC and 1 min at 60uC (40 cycles). A
dissociation step was added at the end of each run to check for
amplification specificity. Twenty-two target genes and two
endogenous control genes (GAPDH and beta-actin) were ana-
lyzed. The characteristics of the samples are shown in Table1.
The 2{DDCT [81] was applied to calculate relative quantification of
target genes. For each target gene, the threshold cycles (CT ) of
samples provided from the equipment software (SDS 2.4) were
normalized by the average CT of both controls using
DC
T , T arg et
~C
T , T arg et
{CT ,AvgControl:. A sample (DCT is very close
to the group mean) from .37 weeks gestation group was then
selected as the reference and then the DCT of all samples were
normalized by this reference using DDCT ,Sample~DCT ,Sample{
DCT ,Reference. Finally, the fold changes of all samples were
calculated by 2{DDCT . All samples were grouped as either ,37
weeks gestation or as .37 weeks gestation. The differences
between the two groups were examined by one way ANOVA.
Pathway and Network Analysis
Pathway enrichment and de novo network discovery were
performed in GeneGO metacore [82]. Pathway enrichment was
calculated using a hypergeometric distribution against both Gene
Ontologies and GeneGo pathway maps. Results were corrected
for FDR using Benjamini-Hochberg. Network discovery was
performed using the ‘‘shortest path’’ and ‘‘direct interactions’’
module. Low confidence, indirect and ‘‘influence by expression’’
interactions were pre-filtered and canonical pathway interactions
were retained.
IlluminaH InfiniumH HD Genome-wide Methylation Assay
Genomic DNA methylation analysis was carried out with 3 sets
of duplicate technical replicates from 20 study subjects. All
subsequent experimental steps followed the manufacturers’
instructions. After extraction of genomic DNA from frozen
umbilical cord specimens according to standard procedures,
1 mg was bisulfite converted using EZ-96 DNA MethylationTM
Gold Kit (Zymo Research, Irvine, CA, USA). Successful
conversion was confirmed via methylation-specific PCR prior to
proceeding with subsequent steps of the Infinium assay protocol.
The bisulfite converted genomic DNA was isothermally amplified
at 37uC for 22 hrs, enzymatically fragmented, purified and
hybridized on an InfiniumH HumanMethlyation 450 BeadChip
(Illumina Inc., San Diego, CA, USA) at 48uC for 18 hrs. After
which, the BeadChip was then washed to remove any un-
hybridized or non-specific hybridized DNA. Labelled single-base
extension was performed on primers hybridized with DNA, and
the hybridized DNA was removed. The extended primers were
stained with multiple layers of fluorescence, the BeadChip was
then coated using a proprietary solution and scanned using the
IlluminaH iScan system. The image data were processed with the
Genome StudioTM Methylation Module software.
The intensity files (.idat) produced by the Illumina iSCAN
system were loaded into GenomeStudio’s methylation module for
signal extraction. Background subtraction was performed by
averaging the signals from the internal negative control beads.
CpGs with less than three beads for either probe for any sample
(18,603), or with signal detection p-values (calculated from the
individual bead intensities) less than 0.05 (2,949) for any sample,
were discarded for all samples. This step removed 4.4% of the
485,577 CpGs assayed. Data were normalized to the internal
controls, which were designed to be housekeeping genes with no
CpGs in the probe (samples the variation inherent in the array). b-
values were then calculated, which are the ratio of the methylated
probe intensity and the overall intensity. The b-value for an ith




Where yi,unmethy and yi,unmethy are the intensities measured by
the ith methylated and unmethylated probes respectively, averaged
over the replicate beads, and ‘‘a ’’ is a constant offset(by default
100). Therefore b -values range between 0–1, with 0 representing
no methylation and 1 representing 100% methylation.
Tables of CpG b-values across samples were exported from
GenomeStudio and loaded into Arraystudio for downstream
analysis. As a further QC step MAD scores were calculated for the
sample sets. MAD is a robust measure of statistical dispersion and






Samples with a MAD score of less than 25 were discarded.
Principal component analysis and hierarchical clustering were
performed to observe the clustering of technical replicates and
discernible batch effects. No batch effects were observed. The
intra-sample deviation was lower than the inter-sample deviation.
Regression analysis was performed against gestational age to
identify CpGs whose methylation levels co-varied. CpGs with a
regression p,0.05, mapping to a gene whose differential
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expression by gestational age was replicated, were reported. No
CpGs passed a Benjamin-Hochberg correction for multiple
testing.
Supporting Information
Figure S1 Hierarchical clustering of the full data set
shows that replicates cluster together. However, there is no
discernable clustering by birthweight or gestational age group.
Each sample is represented as a column in the heatmap and probe
by a row in the heatmap. Heatmap colouring is on normalised
expression level (green= low, white = intermediate, red = high).
Dendogram of sample clustering is above the heatmap. Colour
bars showing sample group (HBW= gold, LBW=green,
#37w_NBW=blue, .37w_NBW=red) and gestational age
(green = low, white = intermediate, red = high).
(TIF)
Figure S2 Tests for differential expression by gesta-
tional age return transcript levels co-varying with
gestational age and significantly different between
gestational age groups. A and B, Examples of significantly
co-varying transcript level by gestational age: probe
A_23_P209246, mapping to the GLI2 (A) and probe
A_23_P70818, mapping to the SMO (B) log2 expression levels
across samples are represented on the y-axis and gestational ages
of those samples are represented on the x-axis. Samples with
gestational age #37 weeks are denoted in blue, .37 weeks in red.
C and D, Results from 1-way ANOVA tests for transcripts whose
expression levels are significantly different between samples with
gestational age #37 weeks and samples with gestational age .37
weeks. Average differences in expression levels between the two
gestational age groups are represented on the x-axis, 2log10
pvalues from the ANOVA tests are represented on the y-axis.
Probes above the horizontal red line have nominal pvalues ,0.05.
Probes in the black box in C have FDR corrected pvalue,0.05.
Transcripts mapping the genes mentioned in the text are
highlighted in red and labelled. C, contains only samples of
normal birthweight i.e.#37w_NBW vs..37w_NBW. D, includes
all samples i.e. LBW and#37w_NBW vs..37w_NBW and HBW.
(TIF)
Figure S3 Example of significantly co-varying tran-
script level by birthweight: probe A_33_P331451 (map-
ping to the TGFBR1) log2 expression levels across
samples are represented on the y-axis and birth weights
of those samples are represented on the x-axis. LBW
samples are denoted in green, NBW samples in purple and HBW
samples in blue.
(TIF)
Table S1 Probes whose expression levels co-varied with
gestational age with a p,0.001 by Pearson’s regression.
(XLSX)
Table S2 Probes whose expression levels co-varied with
birth weight with a p,0.001 by Pearson’s regression.
(DOCX)
Table S3 Probes whose expression levels were signifi-
cantly different between gestational age groups with
FDR corrected pvalue of ,0.005.
(DOCX)
Table S4 Probes whose expression levels co-varied with
birth weight (p,0.001 by Pearson’s) and were signifi-
cantly different between birth weight groups (p,0.05 by
ANOVA) and had a fold change between birthweight
groups of .1.5.
(DOCX)
Table S5 20 genes studied in expanded sample set of
120 by qPCR. The replicating group comprises genes whose
mRNA levels had a significant relationship with gestational age in
the qPCR expanded study. The non-replicating group are those
genes whose mRNA levels did not achieve significance against
gestational age in the expanded qPCR study.
(DOCX)
Table S6 Genes containing probes whose transcript
levels were significantly different between birthweight
groups in the microarray analysis and also containing
CpGs whose methylation levels correlated with birth-
weight in the Infinium analysis.
(DOCX)
Text S1 Detailed description analysis of correlation
between mRNA level and DNA methylation state across
samples paired fro gestational age. Four CpGs from table 2
in CHRDL2, GLI2 and HSD11B1 had significant (p,0.05)
correlation of GA ratios between RNA expression and DNA
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